Bank of New York Mellon’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Buy
132,150
+17,910
+16% +$268K ﹤0.01% 2746
2025
Q1
$1.84M Buy
114,240
+10,552
+10% +$170K ﹤0.01% 2723
2024
Q4
$2.41M Sell
103,688
-1,118
-1% -$26K ﹤0.01% 2666
2024
Q3
$3.08M Sell
104,806
-12,880
-11% -$379K ﹤0.01% 2548
2024
Q2
$2.77M Buy
117,686
+111,636
+1,845% +$2.62M ﹤0.01% 2612
2024
Q1
$229K Buy
+6,050
New +$229K ﹤0.01% 3885
2023
Q3
Sell
-929
Closed -$10.5K 4395
2023
Q2
$10.5K Hold
929
﹤0.01% 4326
2023
Q1
$6.74K Hold
929
﹤0.01% 4369
2022
Q4
$10.5K Hold
929
﹤0.01% 4417
2022
Q3
$12K Sell
929
-76
-8% -$982 ﹤0.01% 4493
2022
Q2
$13K Sell
1,005
-5,301
-84% -$68.6K ﹤0.01% 4532
2022
Q1
$362K Sell
6,306
-65
-1% -$3.73K ﹤0.01% 3902
2021
Q4
$757K Sell
6,371
-9
-0.1% -$1.07K ﹤0.01% 3550
2021
Q3
$1.27M Buy
6,380
+484
+8% +$96.2K ﹤0.01% 3257
2021
Q2
$1.03M Buy
5,896
+165
+3% +$28.7K ﹤0.01% 3400
2021
Q1
$1.14M Sell
5,731
-301
-5% -$59.6K ﹤0.01% 3253
2020
Q4
$1.19M Sell
6,032
-24
-0.4% -$4.72K ﹤0.01% 3166
2020
Q3
$1.07M Buy
6,056
+427
+8% +$75.7K ﹤0.01% 3087
2020
Q2
$1.3M Buy
5,629
+1,825
+48% +$422K ﹤0.01% 2950
2020
Q1
$443K Buy
3,804
+190
+5% +$22.1K ﹤0.01% 3434
2019
Q4
$691K Buy
3,614
+30
+0.8% +$5.74K ﹤0.01% 3420
2019
Q3
$690K Sell
3,584
-237
-6% -$45.6K ﹤0.01% 3367
2019
Q2
$654K Buy
3,821
+1,361
+55% +$233K ﹤0.01% 3468
2019
Q1
$495K Buy
2,460
+481
+24% +$96.8K ﹤0.01% 3558
2018
Q4
$371K Buy
1,979
+206
+12% +$38.6K ﹤0.01% 3622
2018
Q3
$424K Buy
1,773
+117
+7% +$28K ﹤0.01% 3708
2018
Q2
$438K Buy
+1,656
New +$438K ﹤0.01% 3684
2018
Q1
Sell
-530
Closed -$72K 4384
2017
Q4
$72K Hold
530
﹤0.01% 4132
2017
Q3
$65K Hold
530
﹤0.01% 4065
2017
Q2
$51K Sell
530
-312
-37% -$30K ﹤0.01% 4128
2017
Q1
$157K Buy
+842
New +$157K ﹤0.01% 3932